Part B

Displaying 251 - 260 of 1634

SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements

View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.

SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements

View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.

Tools & forms: Appeals

Use these self-service tools and forms to appeal claim decisions.

Tools & forms: Appeals

Use these self-service tools and forms to appeal claim decisions.

Tools & forms: Compliance / Review

Access tools and forms related to the prior authorization program, CERT, and provider audit.

Tools & forms: Compliance / Review

Access tools and forms related to the prior authorization program, CERT, and provider audit.

Oncology

View all Oncology-related articles >> Spotlight

MLN Connects Special Edition for April 16, 2026

View the updated announcement and updated link for the April 16 webinar from CMS.

MLN Connects Special Edition for April 15, 2026

CMS will host an informational webinar April 16 to provide an overview of CMS Interoperability Standards & Prior Authorization for Drugs proposed rule.

MLN Connects Special Edition for April 16, 2026

View the updated announcement and updated link for the April 16 webinar from CMS.